產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-ANGPTL5抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢(xún)訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-ANGPTL5抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-ANGPTL5
Cat. Number:
Anti-ANGPTL5抗體KL-7046R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Angptl5 (angiopoietin-like 5)Anti-ANGPTL5抗體is a 388 amino acid secreted protein that contains one fibrinogen C-terminal domain and is primarily expressed in ***** heart tissue. The gene encoding Angptl5 maps to human chromosome 11. With approximately 135 million base pairs and 1,400 genes, chromosome 11 comprises approximately 4% of human genomic DNA and is considered a gene and disease association dense chromosome. The chromosome 11 encoded Atm gene is important for regulation of cell cycle arrest and apoptosis following double strand DNA breaks. Atm mutation leads to the disorder known as ataxia-telangiectasia. The blood disorders Sickle cell anemia and thalassemia are caused by HBB gene mutations, while Wilms' tumors, WAGR syndrome and Denys-Drash syndrome are associated with mutations of the WT1 gene. Jervell and Lange-Nielsen syndrome, Jacobsen syndrome, Niemann-Pick disease, hereditary angioedema and Smith-Lemli-Opitz syndrome are also associated with defects in chromosome 11-encoded genes.
Also known as:
Angiopoietin like 5; Anti-ANGPTL5抗體Angiopoietin related protein 5; Angiopoietin-like protein 5; Angiopoietin-related protein 5; ANGL5_HUMAN; ANGPTL 5; ANGPTL5; Fibrinogen like; hide
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Chicken, Pig, Horse, Sheep, .
●
Immunogen: KLH conjugated synthetic peptide derived from human ANGPTL5.
●
Predicted Molecular Weight: 41kDa.
Storage:
Shipped at 4℃, Anti-ANGPTL5抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500Anti-ANGPTL5抗體 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl141Ra01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl141Si01 尿激酶型纖溶酶原激活因子受體(ukl)多克隆抗體 Polyclonal Antibody to Plasminogen Activator, Urokinase Receptor (ukl)
kl142Hu01 細(xì)胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl142Mu01 細(xì)胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl142Rb51 細(xì)胞間粘附分子5(ICAM5)多克隆抗體 Polyclonal Antibody to Intercellular Adhesion Molecule 5 (ICAM5)
kl143Ca01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Eq01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Ga01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl143Po01 血管內(nèi)皮生長(zhǎng)因子A(VEGFA)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor A (VEGFA)
kl144Bo01 血管內(nèi)皮生長(zhǎng)因子B(VEGFB)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor B (VEGFB)
kl145Bo01 血管內(nèi)皮生長(zhǎng)因子C(VEGFC)多克隆抗體 Polyclonal Antibody to Vascular Endothelial Growth Factor C (VEGFC)
